We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Microbial Identification System Identifies Cause of Bacterial Contamination

By LabMedica International staff writers
Posted on 03 Sep 2009
An identification system, which can identify 1,044 species of bacterium, solved a contamination problem in a renal dialysis center.

Doctors and scientists first tried unsuccessfully to identify the bacterium causing contamination in a renal care center (San Jose, CA, USA) using a standard hospital microbial identification system. More...
The microbial identification systems routinely used by hospitals can only identify about 300 bacterial species.

The investigating team from Stanford University (Palo Alto, CA, USA), then used Biolog's (Hayward, CA, USA) GEN III system and identified the contaminant in the renal care center as a Halomonas bacterium. The GEN III system is an easy system to use as it is built around a single test panel that can identify both Gram-negative and Gram-positive bacteria without a Gram stain. The finding was verified by 16s ribosomal DNA (rDNA) sequencing, a more complicated and costly molecular identification method.

Biolog has microbiology test kits capable of identifying environmental as well as known pathogenic bacteria species infecting humans, animals, and even plants. The bacterial contaminant Halomonas is typically found in high salt environments such as salt ponds. Normally, one would not expect to find this bacterium in a hospital clinic. In this case, the investigators believe that the bacterium was a contaminant of the sodium bicarbonate solutions that are routinely used to prepare dialysis fluid.

"Bacteria are enterprising, and they will get into and thrive in any environment that they can adapt to and grow in,” said Barry Bochner, Ph.D., CEO and CSO at Biolog "This is why it is important for microbiology labs to use identification methods with broader capabilities. It is not reasonable to assume that environmental bacteria will not find ways to cause contamination and infections.”

Biolog is a privately held company that develops new cell analysis tools for solving critical medical laboratory, pharmaceutical, and biotechnological problems.

The findings were published in July 2009 in the journal Medicine.

Related Links:
Stanford University
Biolog



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Pipette Calibration System
Artel PCS®
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Molecular Diagnostics

view channel
Image: Spatial profiling of muscle-invasive bladder cancer reveals how distinct tumor cell states are organized within individual tumors (Image Credit: Shutterstock)

Spatial Map Guides Treatment Selection in Muscle-Invasive Bladder Cancer

Muscle-invasive bladder cancer is clinically heterogeneous, with patients often responding very differently to therapy. Existing biomarkers do not fully explain these disparities, limiting precision treatment... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.